$ISR Recent Headlines Wednesday's biggest gain
Post# of 44836
Posted On: 12/03/2014 11:52:38 AM
$ISR Recent Headlines
Wednesday's biggest gaining and declining stocks 3:44 p.m. Aug. 19, 2009 - MarketWatch
IsoRay up premarket on brain cancer results 9:24 a.m. Dec. 1, 2014 - Seeking Alpha
Accuray CyberKnife M6 System Now Available in Manhattan - Analyst Blog 6:05 p.m. Nov. 19, 2014 - Zacks.com
10-Q: ISORAY, INC. 4:06 p.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
IsoRay jumps on report of single surgery 11:54 a.m. Oct. 7, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 10:02 a.m. Oct. 7, 2014 - TheStreet.com
Ad Comm smacks down Sonacare's HIFU device for prostate cancer 12:53 p.m. Oct. 3, 2014 - Seeking Alpha
10-K: ISORAY, INC. 3:44 p.m. Sept. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Top Swing Trade Ideas for Thursday, Aug. 21: Alcoa, Sodastream, More 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Why IsoRay (ISR) Stock Is Spiking Today 10:41 a.m. July 14, 2014 - TheStreet.com
First Cesium-131 seed implanted 8:02 a.m. July 14, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 9:38 a.m. June 24, 2014 - TheStreet.com
First patient treated with Cesitrex 8:24 a.m. June 24, 2014 - Seeking Alpha
More on IsoRay fiscal Q3 results 9:16 a.m. May 16, 2014 - Seeking Alpha
10-Q: ISORAY, INC. 4:18 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why IsoRay (ISR) Stock Is Surging Today 10:10 a.m. May 12, 2014 - TheStreet.com
IsoRay's Liquid Cesium-131 receives final OK for use in brain cancer 9:02 a.m. May 12, 2014 - Seeking Alpha
IsoRay (ISR) Is Today's Dead Cat Bounce Stock 8:46 a.m. May 12, 2014 - TheStreet.com
Perilous Reversal Watch: IsoRay (ISR) 8:49 a.m. May 8, 2014 - TheStreet.com
Irrational exuberance is alive and well with IsoRay 9:33 a.m. April 30, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 9:30 a.m. April 30, 2014 - TheStreet.com
IsoRay's Cesium-131 Therapy Stops Brain Cancers from Recurring in Treated Locations Where Previous Conventional Treatments Failed 8:20 a.m. Dec. 1, 2014 - ACCESSWIRE
IsoRays Cesium-131 Therapy Stops Brain Cancers from Recurring in Treated Locations Where Previous Conventional Treatments Failed 8:01 a.m. Dec. 1, 2014 - eTeligis
IsoRay, Inc. Reports First Quarter Results 8:01 a.m. Nov. 17, 2014 - eTeligis
IsoRay Celebrates 10 Year Success Story With the First Prostate Patient Treated With Cesium-131 7:31 a.m. Oct. 29, 2014 - ACCESSWIRE
IsoRay Celebrates 10 Year Success Story With the First Prostate Patient Treated With Cesium-131 7:17 a.m. Oct. 29, 2014 - eTeligis
Pre-market Biotech Picks - Gilead Sciences, MannKind, IsoRay, Orexigen Therapeutics, and Sunesis Pharma 8:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain Cancer 7:16 a.m. Oct. 7, 2014 - Marketwire
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain Cancer 7:06 a.m. Oct. 7, 2014 - eTeligis
IsoRay, Inc. Reports Fiscal Year 2014 Results 7:46 a.m. Sept. 30, 2014 - Marketwire
IsoRay's Cesium-131 Cancer Treatment Products and Methods to Be Featured in Oral Presentations by Industry Leaders During the American Society for Radiation Oncology Convention (ASTRO) 7:31 a.m. Sept. 9, 2014 - Marketwire
ISORAYS CESIUM-131 CANCER TREATMENT PRODUCTS AND METHODS TO BE FEATURED IN ORAL PRESENTATIONS BY INDUSTRY LEADERS DURING THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY CONVENTION (ASTRO) 7:17 a.m. Sept. 9, 2014 - eTeligis
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 8:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery 7:33 a.m. Aug. 5, 2014 - Marketwire
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery 7:16 a.m. Aug. 5, 2014 - eTeligis
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences 7:40 a.m. July 31, 2014 - PR Newswire - PRF
IsoRay Makes First Cesium-131 Delivery for Treatment of an Inoperable Brain Cancer Afflicting a Young Child in Peru 7:31 a.m. July 14, 2014 - Marketwire
IsoRay Makes First Cesium-131 Delivery for Treatment of an Inoperable Brain Cancer Afflicting a Young Child in Peru 7:16 a.m. July 14, 2014 - eTeligis
IsoRay Announces Its Addition to the Russell Microcap Index 7:45 a.m. June 30, 2014 - Marketwire
IsoRay Announces World's First Liquid Cesium-131 (Cesitrex(R)) Treatment for Metastatic Brain Cancer Utilizing the GliaSite(R) Radiation Therapy Balloon Catheter System 7:46 a.m. June 24, 2014 - Marketwire
Health Care Sector Stocks Technical Analysis -- Research on United Therapeutics, IsoRay, Bruker, and Affymetrix 6:50 a.m. June 23, 2014 - PR Newswire - PRF
Wednesday's biggest gaining and declining stocks 3:44 p.m. Aug. 19, 2009 - MarketWatch
IsoRay up premarket on brain cancer results 9:24 a.m. Dec. 1, 2014 - Seeking Alpha
Accuray CyberKnife M6 System Now Available in Manhattan - Analyst Blog 6:05 p.m. Nov. 19, 2014 - Zacks.com
10-Q: ISORAY, INC. 4:06 p.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
IsoRay jumps on report of single surgery 11:54 a.m. Oct. 7, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 10:02 a.m. Oct. 7, 2014 - TheStreet.com
Ad Comm smacks down Sonacare's HIFU device for prostate cancer 12:53 p.m. Oct. 3, 2014 - Seeking Alpha
10-K: ISORAY, INC. 3:44 p.m. Sept. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Top Swing Trade Ideas for Thursday, Aug. 21: Alcoa, Sodastream, More 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Why IsoRay (ISR) Stock Is Spiking Today 10:41 a.m. July 14, 2014 - TheStreet.com
First Cesium-131 seed implanted 8:02 a.m. July 14, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 9:38 a.m. June 24, 2014 - TheStreet.com
First patient treated with Cesitrex 8:24 a.m. June 24, 2014 - Seeking Alpha
More on IsoRay fiscal Q3 results 9:16 a.m. May 16, 2014 - Seeking Alpha
10-Q: ISORAY, INC. 4:18 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why IsoRay (ISR) Stock Is Surging Today 10:10 a.m. May 12, 2014 - TheStreet.com
IsoRay's Liquid Cesium-131 receives final OK for use in brain cancer 9:02 a.m. May 12, 2014 - Seeking Alpha
IsoRay (ISR) Is Today's Dead Cat Bounce Stock 8:46 a.m. May 12, 2014 - TheStreet.com
Perilous Reversal Watch: IsoRay (ISR) 8:49 a.m. May 8, 2014 - TheStreet.com
Irrational exuberance is alive and well with IsoRay 9:33 a.m. April 30, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 9:30 a.m. April 30, 2014 - TheStreet.com
IsoRay's Cesium-131 Therapy Stops Brain Cancers from Recurring in Treated Locations Where Previous Conventional Treatments Failed 8:20 a.m. Dec. 1, 2014 - ACCESSWIRE
IsoRays Cesium-131 Therapy Stops Brain Cancers from Recurring in Treated Locations Where Previous Conventional Treatments Failed 8:01 a.m. Dec. 1, 2014 - eTeligis
IsoRay, Inc. Reports First Quarter Results 8:01 a.m. Nov. 17, 2014 - eTeligis
IsoRay Celebrates 10 Year Success Story With the First Prostate Patient Treated With Cesium-131 7:31 a.m. Oct. 29, 2014 - ACCESSWIRE
IsoRay Celebrates 10 Year Success Story With the First Prostate Patient Treated With Cesium-131 7:17 a.m. Oct. 29, 2014 - eTeligis
Pre-market Biotech Picks - Gilead Sciences, MannKind, IsoRay, Orexigen Therapeutics, and Sunesis Pharma 8:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain Cancer 7:16 a.m. Oct. 7, 2014 - Marketwire
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain Cancer 7:06 a.m. Oct. 7, 2014 - eTeligis
IsoRay, Inc. Reports Fiscal Year 2014 Results 7:46 a.m. Sept. 30, 2014 - Marketwire
IsoRay's Cesium-131 Cancer Treatment Products and Methods to Be Featured in Oral Presentations by Industry Leaders During the American Society for Radiation Oncology Convention (ASTRO) 7:31 a.m. Sept. 9, 2014 - Marketwire
ISORAYS CESIUM-131 CANCER TREATMENT PRODUCTS AND METHODS TO BE FEATURED IN ORAL PRESENTATIONS BY INDUSTRY LEADERS DURING THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY CONVENTION (ASTRO) 7:17 a.m. Sept. 9, 2014 - eTeligis
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 8:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery 7:33 a.m. Aug. 5, 2014 - Marketwire
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery 7:16 a.m. Aug. 5, 2014 - eTeligis
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences 7:40 a.m. July 31, 2014 - PR Newswire - PRF
IsoRay Makes First Cesium-131 Delivery for Treatment of an Inoperable Brain Cancer Afflicting a Young Child in Peru 7:31 a.m. July 14, 2014 - Marketwire
IsoRay Makes First Cesium-131 Delivery for Treatment of an Inoperable Brain Cancer Afflicting a Young Child in Peru 7:16 a.m. July 14, 2014 - eTeligis
IsoRay Announces Its Addition to the Russell Microcap Index 7:45 a.m. June 30, 2014 - Marketwire
IsoRay Announces World's First Liquid Cesium-131 (Cesitrex(R)) Treatment for Metastatic Brain Cancer Utilizing the GliaSite(R) Radiation Therapy Balloon Catheter System 7:46 a.m. June 24, 2014 - Marketwire
Health Care Sector Stocks Technical Analysis -- Research on United Therapeutics, IsoRay, Bruker, and Affymetrix 6:50 a.m. June 23, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼